MENU
+Compare
HROW
Stock ticker: NASDAQ
AS OF
Dec 26, 04:59 PM (EDT)
Price
$50.14
Change
-$0.02 (-0.04%)
Capitalization
1.86B

HROW Harrow Forecast, Technical & Fundamental Analysis

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HROW with price predictions
Dec 24, 2025

HROW in +10.82% Uptrend, growing for three consecutive days on December 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HROW advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for HROW just turned positive on December 23, 2025. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

HROW moved above its 50-day moving average on December 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HROW crossed bullishly above the 50-day moving average on December 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 229 cases where HROW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HROW moved out of overbought territory on December 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HROW as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HROW broke above its upper Bollinger Band on December 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HROW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (39.526) is normal, around the industry mean (24.266). P/E Ratio (0.000) is within average values for comparable stocks, (74.353). HROW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.954). HROW has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (7.299) is also within normal values, averaging (64.216).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HROW is expected to report earnings to rise 17.61% to 38 cents per share on March 25

Harrow HROW Stock Earnings Reports
Q4'25
Est.
$0.39
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of 33 cents, beating the estimate of 23 cents. With 211.67K shares outstanding, the current market capitalization sits at 1.86B.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CXXRX23.080.08
+0.35%
Columbia Small Cap Index Inst2
TASHX16.250.05
+0.31%
Transamerica Multi-Asset Income A
WFPAX44.400.10
+0.23%
Allspring Special Mid Cap Value A
THPBX24.650.05
+0.20%
BNY Mellon Balanced Opportunity J
HSCVX13.02N/A
N/A
Hunter Small Cap Value I

HROW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+2.05%
AMRX - HROW
34%
Loosely correlated
+0.23%
TKNO - HROW
34%
Loosely correlated
+0.24%
VTRS - HROW
34%
Loosely correlated
+1.83%
OGI - HROW
30%
Poorly correlated
+1.15%
ASRT - HROW
30%
Poorly correlated
-0.02%
More

Groups containing HROW

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+2.05%
Pharmaceuticals: Generic
industry (212 stocks)
42%
Loosely correlated
+6.34%